Biology of the Oral Epithelium of E-Cigarette Smokers
1 other identifier
observational
105
1 country
1
Brief Summary
Electronic cigarettes (EC) are battery powered nicotine delivery devices that aerosolize nicotine and other flavor constituents. Despite the increasing use of EC, little attention has been paid to their possible adverse effects on human health. Theoretically, the risk relates to nicotine per se and/or the propellants or contaminants in the EC aerosol. The hypothesis underlying the proposal is that chronic EC smoking disorders the biology of the oral epithelium, the first cell population exposed to inhaled EC vapors. Using a cross-sectional, cohort-comparison of EC smokers compared to age-, gender- and ethnicity-matched never smokers, the investigators propose to assess the oral epithelium obtained by punch biopsy or brushing from 100 EC smokers and 25 nonsmoker controls. The EC study cohort will be restricted to young adults (age 21-35 yr) with no prior history of tobacco smoking, but who have smoked EC for \>6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2016
CompletedFirst Submitted
Initial submission to the registry
January 11, 2017
CompletedFirst Posted
Study publicly available on registry
January 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2021
CompletedMay 4, 2021
April 1, 2021
2.8 years
January 11, 2017
April 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The biology of participants oral epithelial cells
Biopsies will be collected from the buccal mucosa of chronic EC smokers and healthy nonsmoker controls, none of whom have a history of smoking any tobacco products
1-2 months
Secondary Outcomes (1)
The biology of the genes of the oral epithelium
1-2 months
Study Arms (2)
HEALTHY VOLUNTEER RESEARCH SUBJECTS
Healthy as defined by those not having lung disease and inclusive of: all races, ethnicities, sex, HIV status, smoking status and multiple birth status, etc., within the general population. Between the ages of 21-35 years old.
HEALTHY E-CIGARETTE SMOKING SUBJECTS
Criteria is identical to the healthy never-smoker group except that they must have a history of smoking e-cigarettes \>5 days/wk for a minimum of 6 months with no prior traditional tobacco exposure.
Eligibility Criteria
The investigators plan recruit the EC smoking (also called "vaping") population, and have experience recruiting from the extensive network of EC shops and vaping "bars" in the New York City metropolitan area, providing ample access to young adult, sole EC smokers. The control groups will be age-, gender- and ethnicity-matched healthy nonsmokers. Based on our experience with this population, the investigators know that the variables of EC smoking history (brand, flavorings, length and extent of EC smoking history) demand that there is sufficient "n" to power the analysis. In this regard, the study population will include n=125, including n=100 EC smokers and a control group of n=25 healthy nonsmokers. Between the ages of 21-35 years old.
You may qualify if:
- HEALTHY VOLUNTEER RESEARCH SUBJECTS:
- Males and females, ages 21 to 35
- Must be capable of providing informed consent
- Self-reported never-smokers of any type, including chewing tobacco, with current smoking status validated by the absence of nicotine metabolites in urine (nicotine \<2 ng/ml and cotinine \<5 ng/ml)
- No bleeding diathesis
- Normal physical examination
- Good overall health without history of oral or lung disease
- Normal routine laboratory evaluation, including general hematologic studies, general serologic/immunologic studies, general biochemical analyses, and urine analysis
- Not taking any medications relevant to lung disease or having an effect on the airway epithelium
- Normal chest X-ray (PA and lateral)
- Normal electrocardiogram (sinus bradycardia, premature atrial contractions are permissible)
- Females - not pregnant
- Willingness to participate in the study
- HEALTHY VOLUNTEER E-CIGARETTE SMOKING SUBJECTS:
- Males and females, ages 21 to 35
- +10 more criteria
You may not qualify if:
- HEALTHY VOLUNTEER RESEARCH SUBJECTS:
- Have smoked any form of tobacco
- Current marijuana smokers (within the last three months)
- Current active infection or acute illness of any kind
- Evidence of malignancy, including oral cancer
- Current pregnancy
- HEALTHY VOLUNTEER E-CIGARETTE SMOKING SUBJECTS:
- Have smoked any form of tobacco
- Current marijuana smokers (within the last three months)
- Current active infection or acute illness of any kind
- Evidence of malignancy, including oral cancer
- Current Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Genetic Medicine, Weill Cornell Medical College
New York, New York, 10021, United States
Biospecimen
Specimens collected may include blood, urine and oral epithelium samples from consenting subjects. Subjects will include both e-cigarette smoking individuals and healthy control subjects.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald G Crystal, MD
Weill Medical College of Cornell University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2017
First Posted
January 23, 2017
Study Start
April 12, 2016
Primary Completion
February 12, 2019
Study Completion
January 21, 2021
Last Updated
May 4, 2021
Record last verified: 2021-04